Thank you for taking the time to put together that thoughtful response. It seems to me that if the health passport thing becomes either mandatory (which is legally problematic in the U.S. and presumably much of Europe) or customary for certain live events, then the app would be valuable to the test manufacturer so that they would be willing to share revenues. I don’t think it would take a very large percentage to generate enough revenue to justify a rising share price. So, I guess short-term monetization from the app is speculative but holds some real potential.

While I really like the idea of incorporating quantum dots into vaccines, tests, treatments, but that makes QTMM something of a biotech stock (at least for this application), it would seem that a revenue stream from that wouldn’t develop in the short or medium term, which to me is fine. Those things don’t happen overnight. I think, politically, the pressure to approve tests etc. for COVID would die down by the end of the year so that by the time the testing and application process had been completed, there wont be that much money left on the table emailing for new tests/vaccines/treatments to pick up. But all of this might hasten the use of quantum dots in medicine so that there could be real value showing up in two to three years. And then Donald Trump will say “I’m the one who told them to explore ways of getting the sunlight into the human body. You’re welcome!”